Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Yiliu Formulation in Stage II/III Colorectal Cancer
NCT04459754Phase 2Unknown
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fuzheng yiliu in colorectal cancer (CRC), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Status: unknown.
02
Drugs
fuzheng yiliu
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04459754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459754.